RDY Net Income Growth
Dr. Reddy's Laboratories Ltd Common Stock · Net Income Growth
RDY Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-41.61%period ending
RDY TTM Net Income YoY % (-28.27% → -41.61%)
Year-over-year change
High-resolution chart · PNG
RDY net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -41.6102% | |
| -24.1595% | |
| 5.4214% | |
| 9.9171% | |
| 38.6835% | |
| 37.7006% | |
| 90.9523% | |
| 99.0621% | |
| 53.1023% | |
| 66.9021% | |
| 14.7423% | |
| 40.3287% | |
| 40.1621% | |
| 90.448% | |
| 89.0778% | |
| 213.5189% | |
| 215.052% | |
| 110.2893% | |
| -5.6706% | |
| -54.7494% | |
| -75.0486% | |
| -75.5397% | |
| -37.0423% | |
| -49.6897% | |
| 16.384% | |
| 33.6261% | |
| 24.8613% | |
| 67.5478% | |
| 51.4373% | |
| 91.6684% | |
| 76.3346% | |
| 41.7096% | |
| 21.1929% | |
| -18.5481% | |
| 2.5776% | |
| 4.7903% | |
| -24.3159% | |
| -39.8441% | |
| -60.5005% | |
| -55.9548% | |
| -34.5064% | |
| -9.766% | |
| 12.1526% | |
| 9.7231% | |
| -2.0377% | |
| 3.0862% | |
| -2.6865% | |
| 11.2022% | |
| 36.2969% | |
| 27.1196% | |
| 53.0288% | |
| 25.0938% | |
| 14.5305% | |
| 18.6637% | |
| 35.7325% | |
| 29.5887% | |
| 29.1821% | |
| 734.4193% | |
| 1,513.947% | |
| 935.7411% | |
| 190.2178% | |
| 152.0265% | |
| 118.6993% | |
| 121.608% | |
| -276.8149% | |
| -205.3611% | |
| -201.7789% | |
| -216.084% | |
| -9.4899% | |
| -72.0475% | |
| -61.3974% | |
| -54.4541% | |
| 11.0009% | |
| 100.996% | |
| 263.7592% | |
| 472.386% | |
| 317.3492% | |
| 467.1889% | |
| 510.925% | |
| 514.627% | |
| 56.4129% | |
| -44.2301% | |
| -76.433% | |
| -89.3281% | |
| -70.0184% | |
| -53.0466% | |
| -40.066% | |
| -29.5271% | |
| -23.559% | |
| -31.7008% | |
| -45.3511% | |
| -28.2737% |